West CFO Bernard Birkett transitions to sole CFO; operating duties decentralized

WEST PHARMACEUTICAL SERVICES INC

CFO Bernard Birkett's role narrowed from CFO & COO to solely CFO effective May 1, 2024; operating leadership moves to business segments.
Shareholders elected 11 directors, approved say-on-pay (96.1% for), and ratified PricewaterhouseCoopers as auditor.
Charter amendments eliminating supermajority requirements for transactions and amendments approved with over 99% support.
A shareholder proposal on redundant topics was not presented after SEC no-action letter in West's favor.

item 5.02 item 5.07 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Bernard Birkett

Chief Financial Officer

WST · WEST PHARMACEUTICAL SERVICES INC

Effective: 2024-05-01
Filed: April 26, 2024, 7:59 PM ET

Effective May 1, 2024, Mr. Birkett’s title will be solely Chief Financial Officer (“CFO”), where he will retain financial oversight for both Business Segments, operational oversight of our strategic sourcing function and be involved in key operational issues together with other members of our executive team.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bernard Birkett changed role as Chief Financial Officer at WEST PHARMACEUTICAL SERVICES INC.

Action: role change
Role: Chief Financial Officer

Exact text from the filing

Effective May 1, 2024, Mr. Birkett’s title will be solely Chief Financial Officer (“CFO”), where he will retain financial oversight for both Business Segments, operational oversight of our strategic sourcing function and be involved in key operational issues together with other members of our executive team.

View on SEC.gov

WEST PHARMACEUTICAL SERVICES INC filing history →

Source: SEC EDGAR

accession 0000105770-24-000035

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.